Natixis Advisors, LLC’s Bristol-Myers Squibb Co Position
Does Natixis Advisors, LLC own Bristol-Myers Squibb Co (BMY)? Yes — 708.7K shares worth $43M (+0.06% of its 13F portfolio) as of Q1 2026, up from 641.9K shares the prior filed quarter.
Position Value
$43M
Q1 2026
Shares
708.7K
% of Portfolio
+0.06%
Quarters Held
30
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 708.7K | $43M | +0.06% |
| Q4 2025 | 641.9K | $35M | +0.05% |
| Q3 2025 | 590.3K | $27M | +0.04% |
| Q2 2025 | 545.6K | $25M | +0.04% |
| Q1 2025 | 791.7K | $48M | +0.09% |
| Q4 2024 | 680.8K | $39M | +0.07% |
| Q3 2024 | 446.4K | $23M | +0.05% |
| Q2 2024 | 331.0K | $14M | +0.03% |
| Q1 2024 | 619.4K | $34M | +0.08% |
| Q4 2023 | 588.2K | $30M | +0.08% |
| Q3 2023 | 839.7K | $49M | +0.15% |
| Q2 2023 | 974.8K | $62M | +0.19% |
| Q1 2023 | 927.6K | $64M | +0.22% |
| Q4 2022 | 971.8K | $70M | +0.26% |
| Q3 2022 | 994.2K | $71M | +0.30% |
| Q2 2022 | 1.09M | $84M | +0.37% |
| Q1 2022 | 929.4K | $68M | +0.26% |
| Q4 2021 | 761.9K | $48M | +0.18% |
| Q3 2021 | 694.0K | $41M | +0.17% |
| Q2 2021 | 839.5K | $56M | +0.26% |
| Q1 2021 | 771.1K | $49M | +0.25% |
| Q4 2020 | 729.0K | $45M | +0.26% |
| Q3 2020 | 682.5K | $41M | +0.26% |
| Q2 2020 | 713.1K | $42M | +0.28% |
| Q1 2020 | 632.7K | $35M | +0.29% |
| Q4 2019 | 630.8K | $40M | +0.29% |
| Q3 2019 | 514.4K | $26M | +0.21% |
| Q2 2019 | 276.8K | $13M | +0.10% |
| Q1 2019 | 167.4K | $8M | +0.07% |
| Q4 2018 | 178.7K | $9M | +0.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Natixis Advisors, LLC’s full portfolio or all institutional holders of BMY.